Improving the prediction of coronary heart disease to aid in the management of high cholesterol levels: What a difference a decade makes

JAMA

Volumn 279, Issue 6, 1998, Pages 445-449

  Avins, Andrew L ^a   Browner, Warren S ^b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL;

EID: 0032506954     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.6.445     Document Type: Article

References (23)

1. Adult Treatment Panel II. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 1993;269:3015-3023.
2. Avins AL, Browner WS. Lowering risk without lowering cholesterol: implications for national cholesterol policy. Ann Intern Med. 1996;125:502-506.
3. Davey-Smith G, Egger M. Who benefits from medical interventions? BMJ. 1994;308:72-74.
4. Goldman L, Gordon DJ, Rifkind BM, et al. Cost and health implications of cholesterol lowering. Circulation. 1992;85:1960-1968.
5. McIsaac WJ, Naylor CD, Basinski A. Mismatch of coronary risk and treatment intensity under the National Cholesterol Education Program guidelines. J Gen Intern Med. 1991;6:518-523.
6. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professionals. Circulation. 1991;83:356-362.
7. Garber AM, Browner WS, Hulley SB. Cholesterol screening in asymptomatic adults, revisited. Ann Intern Med. 1996;124:518-531.
8. McDowell A, Engle A, Massey JT, Maurer K. Plan and Operation of the Second National Health and Nutrition Examination Survey 1976-1980. Washington, DC: US Government Printing Office; 1981.
9. Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults: the National Health and Nutrition Examination Surveys. JAMA. 1993;269:3002-3008.
10. US Bureau of the Census. United States Population Estimates, by Age, Sex, Race, and Hispanic Origin, 1996 to 2000. Washington, DC: US Bureau of the Census; 1996.
11. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39: 561-577.
12. Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285-1293.
13. StataCorp. Stata Statistical Software: Release 5.0. College Station, Tex: Stata Corp; 1996.
14. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
15. Mossman D. Resampling techniques in the analysis of non-binormal ROC data. Med Decis Making. 1995;15:358-366.
16. Jacobs DR, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol. 1990;131:32-47.
17. Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, Harlan WR. Cholesterol and heart disease in older persons and women. Ann Epidemiol. 1992;2:161-176.
18. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995; 333:1301-1307.
19. Pedersen TR, Kjekshus J, Olsson A, et al. Scandinavian Simvistatin Study (4S). Lancet. 1994;344: 1765-1768.
20. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
21. Forrester JS, Shah PK. Using serum cholesterol as a screening test for preventing coronary heart disease: the five fundamental flaws of the American College of Physicians guidelines. Am J Cardiol 1997;79:790-792.
22. Glick H, Heyse JF, Thompson D, Epstein RS, Smith ME, Oster G. A model for evaluating the cost-effectiveness of cholesterol-lowering treatment. Int J Technol Assess Health Care. 1992;8:719-734.
23. Perkins KA. Family history of coronary heart disease: is it an independent risk factor? Am J Epidemiol. 1986;124:182-194.